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Introduction
A switch from carbohydrate to fat as a fuel source is a
hallmark of systemic inflammation. This adaptive reaction
allows animals to survive under restricted food supply
conditions. However, a prolonged and excessive stimula-
tion of lipid metabolism may be detrimental.
Objectives
Using our well-characterized 72h fluid-resuscitated rat
model of faecal peritonitis (1), where accurate prognosti-
cation can be made as early as 6h, we investigated differ-
ences in fat metabolism between predicted survivors (S)
and non-survivors (NS).
Methods
Awake, instrumented yet fully mobile male Wistar rats
(325 ± 15g) received an i.p. injection of 4µl/g faecal
slurry. Fluid resuscitation (50:50 mix of 5% glucose/
Hartmann´s; 10ml/kg/h) was commenced at 2h. At 6h,
an echo-measured heart rate cut-off of 460 bpm was
used to classify animals into predicted S or NS. Control
animals were treated identically except for slurry injec-
tion. Blood samples were taken for measurement of hor-
mones and metabolites at 6 and 24h. Results were
analysed using two-way ANOVA and post-hoc testing,
and considered statistically significant when p < 0.05.
Results
At 6h after sepsis initiation, concentrations of the lipoly-
tic agents, adrenaline and brain natriuretic peptide, were
significantly higher in NS (Table 1). The rise in plasma
free fatty acids (FFA) was similar in both S and NS.
Plasma glucagon and the glucagon:insulin ratio were
higher while triglyceride and cholesterol concentrations
were significantly lower in NS; this is perhaps explained
by glucagon-induced repression of hepatic fatty acid and
cholesterol synthesis (2). NS had higher plasma concen-
trations of ketone bodies and acetylcarnitine, suggesting
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Table 1
Control Survival Predicted Non-Survival
Adrenaline 8.56 ± 0.42 9.44 ± 0.23 10.3 ± 0.18
B-natriuretic peptide 118 ± 22 196 ± 35 1318 ± 320a
Glucagon 53 ± 5 62 ± 4 75 ± 5 a
Insulin 0.54 ± 0.25 0.86 ± 0.22 0.87 ± 0.13
Triglycerides 1.22 ± 0.08 1.12 ± 0.04 0.75 ± 0.08 a, b
FFA mg/dL 167 ± 27 514 ± 109 456 ± 122 a
Acetoacetate (AA) µmol/L 91 ± 9 78 ± 57 207 ± 122
3-hydroxybutyrate (3HB)µmol/L 97 ± 8 259 ± 49 355 ± 99 a
Acetylcarnitine µM 9.73 ± 0.40 10.02 ± 0.88 16.75 ± 3.25 a,b
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different utilization of acetylCoA groups between S and
NS. The plasma acetoacetate/3-hydroxybutyrate ratio
was similar in S and NS at 6h but increased at 24h in S
and decreased in NS, reflecting alterations in redox
potential and the hepatic NAD+:NADH ratio (3).
Conclusions
Predicted non-survivor rats demonstrated a greater
stress response to sepsis accompanied by greater altera-
tions in fat metabolism. The consequences of these
changes in energy metabolism on the development of
organ failure merit further investigation, as this may
lead to novel directed therapeutics.
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